دورية أكاديمية
An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis.
| العنوان: | An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis. |
|---|---|
| المؤلفون: | Demyanets S; Department of Internal Medicine II, Medical University of Vienna, Währinger-Gürtel 18-20, 1090 Vienna, Austria; Department of Laboratory Medicine, Medical University of Vienna, Währinger-Gürtel 18-20, 1090 Vienna, Austria. Electronic address: svitlana.demyanets@meduniwien.ac.at., Tentzeris I; 3rd Medical Department for Cardiology and Emergency Medicine, Wilhelminenhospital, Montleartstraße 37, 1160 Vienna, Austria., Jarai R; 3rd Medical Department for Cardiology and Emergency Medicine, Wilhelminenhospital, Montleartstraße 37, 1160 Vienna, Austria., Katsaros KM; Department of Internal Medicine II, Medical University of Vienna, Währinger-Gürtel 18-20, 1090 Vienna, Austria; Ludwig Boltzmann Cluster for Cardiovascular Research, Währinger-Gürtel 18-20, 1090 Vienna, Austria., Farhan S; 3rd Medical Department for Cardiology and Emergency Medicine, Wilhelminenhospital, Montleartstraße 37, 1160 Vienna, Austria., Wonnerth A; Department of Internal Medicine II, Medical University of Vienna, Währinger-Gürtel 18-20, 1090 Vienna, Austria., Weiss TW; 3rd Medical Department for Cardiology and Emergency Medicine, Wilhelminenhospital, Montleartstraße 37, 1160 Vienna, Austria., Wojta J; Department of Internal Medicine II, Medical University of Vienna, Währinger-Gürtel 18-20, 1090 Vienna, Austria; Ludwig Boltzmann Cluster for Cardiovascular Research, Währinger-Gürtel 18-20, 1090 Vienna, Austria., Speidl WS; Department of Internal Medicine II, Medical University of Vienna, Währinger-Gürtel 18-20, 1090 Vienna, Austria., Huber K; 3rd Medical Department for Cardiology and Emergency Medicine, Wilhelminenhospital, Montleartstraße 37, 1160 Vienna, Austria; Ludwig Boltzmann Cluster for Cardiovascular Research, Währinger-Gürtel 18-20, 1090 Vienna, Austria. |
| المصدر: | Cytokine [Cytokine] 2014 Jun; Vol. 67 (2), pp. 65-70. Date of Electronic Publication: 2014 Mar 27. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005353 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0023 (Electronic) Linking ISSN: 10434666 NLM ISO Abbreviation: Cytokine Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2001- > : Oxford : Elsevier Science Ltd. Original Publication: [Philadelphia, PA] : Saunders Scientific Publications, W.B. Saunders, [c1989- |
| مواضيع طبية MeSH: | Stents*, Coronary Restenosis/*blood , Heart Diseases/*blood , Interleukins/*blood, Aged ; Angina, Stable/blood ; Angina, Stable/surgery ; Coronary Angiography ; Coronary Artery Disease/blood ; Coronary Artery Disease/diagnosis ; Coronary Restenosis/diagnosis ; Heart Diseases/surgery ; Humans ; Interleukin-33 ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Myocardial Infarction/blood ; Myocardial Infarction/surgery ; Percutaneous Coronary Intervention/methods |
| مستخلص: | The study aim was to determine the predictive value of interleukin (IL)-33, a recently described member of the IL-1 family of cytokines, for the development of in-stent restenosis (ISR). IL-33 serum levels were measured in 387 consecutive patients undergoing percutaneous coronary intervention (PCI) of whom 193 had stable angina, 93 non-ST elevation myocardial infarction (NSTEMI), and 101 ST-elevation MI (STEMI), respectively. Blood was taken directly before and 24h after stent implantation. The presence of ISR was initially evaluated by clinical means after six to eight months. When presence of myocardial ischemia was suspected, coronary angiography was performed to confirm the suspected diagnosis of ISR. Clinical ISR was present in total in 34 patients (8.8%). IL-33 was detectable in 185 patients and was below detection limit in 202 patients. In patients with decreased IL-33 (n=95), unchanged or non-detectable levels (n=210) or increased levels of IL-33 after PCI (n=82), ISR-rate was 2.1%, 9.5% and 14.6%, respectively (p<0.05). Accordingly, patients with ISR showed a significant increase of IL-33 upon PCI (p<0.05). This association was independent from clinical presentation and risk factors as well as numbers and type of stents. In patients with both stable and unstable coronary artery disease, an increase of IL-33 serum levels after stent implantation is associated with a higher rate of in-stent restenosis. (Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.) |
| References: | Int Immunol. 2008 Aug;20(8):1019-30. (PMID: 18550585) J Exp Med. 2008 Feb 18;205(2):339-46. (PMID: 18268038) Atherosclerosis. 2010 Jan;208(1):285-9. (PMID: 19683238) Mol Cell Biochem. 2010 Feb;335(1-2):75-81. (PMID: 19756962) Nat Rev Immunol. 2006 Jul;6(7):508-19. (PMID: 16778830) J Thromb Haemost. 2005 Feb;3(2):233-9. (PMID: 15670026) Control Clin Trials. 1990 Apr;11(2):116-28. (PMID: 2161310) Cardiovasc Res. 2011 Jul 15;91(2):350-7. (PMID: 21421554) PLoS One. 2008 Oct 06;3(10):e3331. (PMID: 18836528) J Am Coll Cardiol. 2010 Nov 23;56(22):1783-93. (PMID: 21087705) Int J Cardiol. 2013 Sep 1;167(5):2182-8. (PMID: 22835988) Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2781-6. (PMID: 22096097) Cytokine. 2013 May;62(2):272-7. (PMID: 23561929) J Mol Cell Cardiol. 2013 Jul;60:16-26. (PMID: 23567618) Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1769-76. (PMID: 12426203) Am Heart J. 2011 Jun;161(6):1163-70. (PMID: 21641364) JACC Cardiovasc Interv. 2010 Jan;3(1):90-7. (PMID: 20129576) Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2080-9. (PMID: 21737781) JACC Cardiovasc Interv. 2011 Oct;4(10):1057-66. (PMID: 22017929) Immunity. 2009 Jul 17;31(1):84-98. (PMID: 19559631) Clin Rheumatol. 2011 Jun;30(6):825-30. (PMID: 21246230) Nat Rev Immunol. 2010 Feb;10(2):103-10. (PMID: 20081870) Ann Rheum Dis. 2012 Apr;71 Suppl 2:i101-4. (PMID: 22460136) FASEB J. 2005 Dec;19(14):1998-2004. (PMID: 16319143) Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):e121-5. (PMID: 16690873) J Am Coll Cardiol. 2006 Jul 4;48(1):193-202. (PMID: 16814667) Eur J Immunol. 2011 Jun;41(6):1535-8. (PMID: 21618506) Thromb Haemost. 2011 May;105(5):883-91. (PMID: 21359408) Cytokine. 2012 Apr;58(1):6-9. (PMID: 22239947) Curr Mol Med. 2006 Aug;6(5):457-77. (PMID: 16918368) Thromb Haemost. 2011 Nov;106(5):820-6. (PMID: 21866302) J Thromb Haemost. 2008 Mar;6(3):508-13. (PMID: 18182031) J Inflamm (Lond). 2011 Aug 26;8(1):22. (PMID: 21871091) Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):493-500. (PMID: 19505401) Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):8017-22. (PMID: 20385815) Int J Cardiol. 2009 Mar 6;132(3):392-7. (PMID: 18378332) Blood. 2009 Oct 1;114(14):3117-26. (PMID: 19661270) Atherosclerosis. 2006 Jan;184(1):157-62. (PMID: 15950231) Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. (PMID: 21912414) Kardiol Pol. 2009 Jun;67(6):623-30. (PMID: 19618318) J Immunol. 2009 Jul 15;183(2):1446-55. (PMID: 19553541) Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9021-6. (PMID: 19439663) Immunity. 2005 Nov;23(5):479-90. (PMID: 16286016) |
| فهرسة مساهمة: | Keywords: Coronary artery disease; Interleukin-33; Myocardial infarction; Percutaneous coronary intervention; Restenosis |
| المشرفين على المادة: | 0 (IL33 protein, human) 0 (Interleukin-33) 0 (Interleukins) |
| تواريخ الأحداث: | Date Created: 20140415 Date Completed: 20141215 Latest Revision: 20220317 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC3996548 |
| DOI: | 10.1016/j.cyto.2014.02.014 |
| PMID: | 24725541 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!